140 related articles for article (PubMed ID: 32930639)
1. Patent evaluation of WO2019209182 (A1) 2019-10-31 (Conjugated Oligoelectrolytes as Antimicrobial Agents).
Milite C
Expert Opin Ther Pat; 2020 Dec; 30(12):911-915. PubMed ID: 32930639
[TBL] [Abstract][Full Text] [Related]
2. Improving the antimicrobial efficacy against resistant Staphylococcus aureus by a combined use of conjugated oligoelectrolytes.
Bazan EL; Ruan L; Zhou C
PLoS One; 2019; 14(11):e0224816. PubMed ID: 31730663
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Conjugated Oligoelectrolytes Containing Triphenylphosphonium Solubilizing Groups.
Chan SJW; Zhang K; Zhu JY; Bazan GC
Chemistry; 2023 May; 29(26):e202203803. PubMed ID: 36738304
[TBL] [Abstract][Full Text] [Related]
4. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
7. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Polymers: The Potential Replacement of Existing Antibiotics?
Kamaruzzaman NF; Tan LP; Hamdan RH; Choong SS; Wong WK; Gibson AJ; Chivu A; Pina MF
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167476
[TBL] [Abstract][Full Text] [Related]
10. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
Tiwari V; Meena K; Tiwari M
Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
[TBL] [Abstract][Full Text] [Related]
12. Polyhexamethylene guanidine hydrochloride shows bactericidal advantages over chlorhexidine digluconate against ESKAPE bacteria.
Zhou Z; Wei D; Lu Y
Biotechnol Appl Biochem; 2015; 62(2):268-74. PubMed ID: 24888899
[TBL] [Abstract][Full Text] [Related]
13. Membrane-intercalating conjugated oligoelectrolytes: impact on bioelectrochemical systems.
Yan H; Catania C; Bazan GC
Adv Mater; 2015 May; 27(19):2958-73. PubMed ID: 25846107
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
[No Abstract] [Full Text] [Related]
15. Antimicrobial Resistance in
Lupo A; Haenni M; Madec JY
Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
17. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.
Younis W; AbdelKhalek A; Mayhoub AS; Seleem MN
Curr Pharm Des; 2017; 23(14):2147-2157. PubMed ID: 28190396
[TBL] [Abstract][Full Text] [Related]
19. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
Yu Z; Tang J; Khare T; Kumar V
Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the ESKAPE pathogens.
Pendleton JN; Gorman SP; Gilmore BF
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
